Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Jiuzhou Linjia Medical Investment Management is a specialized investment firm based in China that focuses on the healthcare, biotechnology, and pharmaceutical sectors. The company serves as an investment arm associated with Zhejiang Jiuzhou Pharmaceutical, a leading global contract development and manufacturing organization (CDMO). It manages medical industry investment funds, targeting innovative startups and growth-stage companies across the life sciences value chain. Through its strategic investments, the firm seeks to foster synergy with its parent's manufacturing and development capabilities to support the growth of the domestic and international healthcare industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhejiang Jiuzhou Linjia Medical Investment.